PL and PN |
Human plasma |
C18 |
MeOH:ACN:1.0 M ammonium acetate (38:25:45) |
DMB |
350, 390 |
LLE |
3 ng/mL |
Yamaguchi et al. 1991 [65] |
F and E |
Biological samples |
Keystone Hypersil |
H2O:MeOH:ACN (50:33.3:16.7) |
9-AN |
305–395, 430–470 |
SPE |
F: 50 pg E: 70 pg |
Haegele et al. 1991 [48] |
F |
Human serum |
C18 |
1: 10 mM potassium biphthalate 2: ACN Tetrahydrofuran: 19 mM potassium biphthalate (40:6:54) Both adjusted to pH 1.85 with trifluoroacetic acid |
Sulfuric acid-ethanol |
365, 520 |
- |
0.30 pg/dL |
Nozaki et al. 1991 [53] |
F |
Human urine |
C18 |
Gradient of ACN: 36.4 mmol/L phosphate (45:55; pH 1.85 with trifluoroacetic acid) |
Sulfuric acid-ethanol |
365, 520 |
SPE |
0.26 pg/dL |
Nozaki et al. 1992 [54] |
7α-Hydroxycholesterol |
Dog plasma |
Develosil Ph-5 |
Acetonitrile: Water (5:2) |
1-AN |
338, 411 |
LLE |
4 pg |
Saisho et al. 1998 [57] |
Corticosteroids |
Urine |
Silica |
2-Propanol–hexane |
9-AN |
370, 470 |
Enzyme hydrolysis, extraction with 0.5 M NaOH |
NR |
Neufeld et al. 1998 [50] |
F and E |
Human plasma |
C18 |
ACN: 0.3 mM ortho-phosphoric acid (470:530) |
9-AN |
360, 460 |
SPE |
3.0 ng/mL |
Glowka et al. 2009 [45] |
Corticosterone |
Rat urine |
CN |
ACN: H2O (24.5:75.5) |
post-column reaction with sulfuric acid |
460, 510 |
LLE |
0.5 pmol |
Sudo et al. 1990 [55] |
F |
Human hair |
C18 |
MeOH:H2O 60:40 |
sulfuric acid |
360, 480 |
LLE |
1 pg/mg |
Gao et al. 2010 [56] |
EE2, E2, and BPA |
Human urine and aqueous samples |
C18 |
ACN:MeOH:H2O (30:15:55) |
- |
280, 310 |
FPSE |
E2: 20 pg/mL EE2: 36 pg/mL BPA: 42 pg/mL |
Kumar et al. 2014 [81] |
BPA, NP, E2, EE2, and E3 |
Human urine |
C18 |
Gradient elution of ACN and H2O |
p-nitrobenzoyl chloride |
E2, E3: 282, 315 BPA, NP, EE2: 228, 316 |
SPE |
BPA and E2: 2.7 μg/L NP: 2.9 μg/L E2 and EE2: 4.6 μg/L E3: 8.3 μg/L |
Mao et al. 2004 [42] |
E, testosterone, methyltestosterone, bolasterone, testosterone acetate, progesterone |
Urine |
C18 |
0.01 M Tb(NO3)3, 0.1 M sodium dodecyl sulfate (SDS), and 20% acetonitrile |
- |
245, 547 |
SPE |
Down to 100 pg/mL |
Amin et al. 1993 [26] |
BPA and 8 alkylphenols (4-sec-Butylphenol, 2-tert-Butylphenol, 3-tert-butylphenol, 4-tert-butylphenol, 4-n-Pentylphenol, 4-tert-pentylphenol, 4-n-hexylphenol, and 4-n-heptylphenol) |
Rat plasma and blood |
C18 |
MeOH:Water (10:90) |
2-(4-carboxyphenyl)-5,6- dimethylbenzimidazole |
Derivatized: 336, 440 Native: 275, 315 |
LLE |
BPA: 0.1 pg/mL Alkylphenol: 0.7–10 pg/mL |
Katayama et al. 2001 [59] |
progesterone and 17-hydroxyprogesterone dehydroepiandrosterone, androstenedione, testosterone and 17-methyltestosterone |
Serum from pregnant and non-pregnant women |
Wakosil 5C4 |
Acetonitrile:Water (7:3) |
BODIPY FL hydrazide |
495, 516 |
LLE |
550–3700 fmol per 10 μL |
Katayama et al. 1998 [68] |
aldosterone, corticosterone, F, E, dexamethasone, fluocinolone acetonide, triamcinolone and triamcinolone acetonide |
Human plasma |
C18 |
Water:MeOH (25:75) containing 5 mmol/L tetramethylammonium hydrogen sulphate |
CDB |
334, 418 |
LLE |
0.06–0.3 pg per 100 μL |
Katayama et al. 1992 [58] |
BPA |
Breast Milk |
C18 |
1: ACN:H2O:MeOH (72:13:15) 2: ACN:0.1 M acetate buffer (pH 5.5):MeOH (55:12:33) |
DIB-Cl |
350, 475 |
SPE then LLE |
0.11 ng/mL |
Sun et al. 2004 [61] |
BPA |
Human blood serum and ascitic fluid samples |
C18 |
1: ACN: H2O:MeOH (72:13:15) 2: ACN:0.1 M Acetate buffer (pH 5.5):MeOH (55:12:33) |
DIB-Cl |
350, 475 |
LLE |
0.04 ppb |
Kuroda et al. 2003 [62] |
BPA |
Rat brain rat plasma |
C18 |
1: ACN: H2O:MeOH:Tetrahydrofuran (55:10:35:2.5) 2: ACN:0.1 M Acetate buffer (pH 3.0):MeOH (35:10:55) |
DIB-Cl |
350, 475 |
LLE |
0.3 ppb in 60 μL rat brain 4.6 ppb in 50 μL rat plasma |
Sun et al. 2002 [63] |
F, E, PL, PN, 6β-OHF, 6β-OHP and 6β-OHE |
Human plasma and urine |
Cosmosil 5SL |
diethylene dioxide: ethyl acetate:chloroform:n-hexane:pyridine (500:100:100:1400:21) |
9-AN |
360, 460 |
LLE |
F, E, PL and PN: 0.1 ng/mL 6β-OHF and 6β-OHP: 0.5 ng/mL |
Shibata et al. 1997 [47] |
Corticosterone |
Rat serum |
C18 |
60% MeOH: 40% 5 mM triethylamine, pH 3.3 |
- |
375, 485 |
LLE |
0.1 ng |
Mason et al. 1992 [77] |
18-Oxygenated corticosteroids, 18-hydroxycortisol, 18- hydroxycortisone and 18-oxocortisol |
Human urine |
μBondasphere phenyl |
A: 10 mM ammonium acetate: MeOH (50:50) B: ACN |
1-AN |
370, 470 |
LLE and SPE |
0.1 pmol |
Kurosawa et al. 1995 [43] |
Cholesterol and sitosterol |
Saliva and urine biosamples, Cow milk, and Soybean milk |
C8 |
MeOH:isopropanol:H2O (90:5:5) |
naproxen acyl chloride |
231, 352 |
LLE |
25 nM per 10 μL injected volume |
Lin et al. 2007 [79] |
Pregnenolone |
Rat brain |
C18 |
MeOH:H2O (9:1) |
1-AN |
370, 470 |
SPE |
NR |
Shimada et al. 1996 [27] |
C21 steroids; corticoids |
Steroid standards |
C18 |
MeOH:H2O:cyclodextrin |
1-AN |
360, 460 |
NR |
NR |
Shimada et al. 1991 [44] |
Triamcinolone |
Human plasma |
C18 |
ACN and 0.3 mM ortho-phosphoric acid |
9-AN |
360, 460 |
SPE |
1 ng/mL |
Glowka et al. 2006 [88] |
Butane acid-(5-androsten-17-one-3beta-ol)-diester (A1998) |
Rat plasma |
C18 |
25 mM acetate buffer (pH 3.7):ACN Alfaxalone: (45:55) Pregnanolone: (40:60) |
Dansyl hydrazine |
332, 516 |
LLE |
10 ng/mL |
Visser et al. 2000 [69] |
Alfaxalone and pregnanolone |
Rat plasma |
C18 |
Gradient mixture of ACN and H2O |
Dansyl Hydrazine |
350, 520 |
- |
0.025 μg/mL |
Peng et al. 2007 [70] |
EED |
Oral contraceptive tablets |
STAR RP-18e |
ACN:H2O (47:53) |
- |
EED: 285, 310 |
- |
EED: 0.0538 μg/ml |
Sarafinovska et al. 2006 [12] |
EED and drospirenone |
Oral contraceptive tablets |
STAR RP-18e RP |
ACN:H2O (47:53) |
- |
285, 310 |
- |
EED: 0.00065 μg/mL DROSP: 0.0774 μg/mL |
Sarafinovska et al. 2009 [13] |
EED |
Coated tablets |
LiChroCART 100RP |
ACN:H2O (50:50) |
- |
280, 310 |
- |
EED: 0.02 μg/mL |
Silva et al. 2013 [89] |
Sodium E1 sulphate, sodium equilin sulphate, E1 and equilin |
Raw materials and Pharmaceuticals |
5 ODS2 |
TEA phosphate buffer (pH 4.0; 0.05 M):ACN 1— (70:30, v:v) 2—for unconjugated estrogens: (66:34) |
Postcolumn on line photochemical derivatization |
280, 410 or 312 |
- |
0.01–1.38 pmol |
Gatti et al. 1998 [90] |
E1, 17β-Estradiol, E3, BPA, NP, OP |
Fish, chicken, aquaculture pond water sample |
C18 |
Gradient program of 1: H2O: 5% ACN 2: H2O: ACN |
BCEC-Cl |
279, 380 |
DLLME |
0.02–0.07 µg/L |
Wu et al. 2015 [29] |
E1, E2, and E3 |
Cow and river Buffalo |
C18 |
1: ACN:H2O:Formic Acid (40:60:0.4) 2: ACN:H2O:Formic Acid (90:10:0.4) |
- |
280, 310 |
LLE and SPE |
5–10 ng/kg |
Shahbazi et al. 2016 [31] |
α- and β-Trenbolone |
Bovine muscle and liver |
C18 |
MeOH:H2O (60:40) |
- |
364, 460 |
LLE then SPE |
bovine muscle: 0.2 ng/g liver: 1.0 ng/g |
Yoshioka et al. 2000 [33] |
NP, 4-nonylphenol mono-(NP1EO), diethoxylates (NP2EO), BPA, TBP, and OP |
Fish and shellfish |
Inertsil PH |
Gradient program of A: H2O B: MeOH |
- |
275, 300 |
LLE |
NP NP1EO and NP2EO : 2 ng/g BPA, BP and OP: 1 ng/g |
Tsuda et al. 2000 [32] |
Nonylphenol and its ethoxylates |
Fish tissue |
Hypersil APS |
Hexane:ethanol (98:2) |
- |
230, 300 |
Pressurized fluid extraction |
4–15 ng/mL |
Datta et al. 2002 [28] |
E2 and EE2 |
Poultry litter |
C18 |
Gradient program of A: H2O B: ACN |
- |
280, 312 |
LLE |
E2: 4.0 μg/kg EE2: 2.6 μg/kg |
Lu et al. 2014 [91] |
E2 and EE2 |
Waste Water |
C18 |
Gradient program of A: H2O B: ACN |
- |
282, 306 |
SPE |
2.5 ng/L |
Liz et al. 2017 [17] |
E3, E2, EE2, HEX, mestranol |
Water, sediment |
Poroshell 120 EC |
H2O:ACN 50:50 |
- |
275, 310 |
SPE |
Water: 6–24 ng/L Sediment: 0.1–0.9 ng/g |
Perez et al. 2015 [92] |
E2, 17α-EE2, and E1 |
Water |
C18 |
Gradient program of A: ACN B: H2O acidified at pH 3.6 with glacial acetic acid |
- |
230, 302 |
SPE |
10 to 1100 ng/L |
Patrolecco et al. 2013 [93] |
OP, NP, BPA, diethylstilbestrol, E1, EE2, E2, and E3 |
Wastewater samples |
C18 |
Gradient program of A: 5% ACN B: ACN |
EASC |
262, 430 |
SPE |
0.3–0.7 ng/L |
Zhang et al. 2012 [52] |
E2 and EE2 |
Tap, surface and waste water |
C18 |
Water:acetonitrile mixture (50:50) |
- |
280, 310 |
DLLME |
E2: 2.0 ng/L EE2: 6.5 ng/L |
Lima et al. 2013 [37] |
BPA, 17β-estradiol, and 17α-ethynyl estradiol |
Drinking water |
LiChro-sorbs RP18 |
10 mM H3PO4:55% MeOH (45:55) |
- |
280, 310 |
PAC |
BPA: 201 ng/L E2: 313 ng/L EE2: 284.5 ng/L |
Yoon et al. 2003 [94] |
17α- and 17β-Trenbolone |
River water |
C18 |
Gradient program of MeOH:H2O |
- |
359, 458 |
SPE |
4 ng/L |
Durhan et al. 2005 [95] |
NP, OP, NP polyethoxylates |
municipal wastewater treatment plants |
C18 |
Gradient program of H2O:ACN |
- |
229, 310 |
LLE |
OP: 2 ng/L NP: 11 ng/L NPE: 52 ng/L |
Snyder et al. 1999 [5] |
E2, E3, BPA, and 17β-ethinylestradiol |
environmental waters |
C18 |
ACN:0.02 mol/L phosphate solution (45:55) |
- |
227, 315 |
Synthesized in-tube SPME device |
0.006–0.10 ng/mL |
Wen et al. 2006 [96] |
E2, E3, EE2, 3-methyl ether EE2, NP, OP, POE(1-2) nonyl phenol and BPA |
River water |
C18 |
Gradient program of Milli-Q H2O and ACN |
- |
230, 290 |
on-line SPE |
20–50 ng/L |
Ying et al. 2002 [97] |
Endocrine disruptors; BPA and EE2 |
Environmental water samples |
C18 |
MeOH:0.025 mol/L Na2HPO4 buffer (70:30) |
- |
220, 315 |
A poly(acrylamide-vinylpyridine) monolithic capillary column |
BPA: 0.064 ng/mL 17α-ethinylestradiol: 0.12 ng/mL |
Fan et al. 2005 [98] |
Brassinosteroids |
Plant: (Vicia faba L.) |
C18 |
ACN: H2O (90:10) |
9-Phenanthreneboronic acid |
305, 375 |
LLE |
50 pg |
Gamoh et al. 1989 [51] |
Brassinolide |
Arabidopsis thaliana, Daucus carota and Brassica campestris L. leaves’ samples |
C18 |
Gradient program of A: H2O and ACN B: ACN and 0.1% Formic Acid |
- |
305, 375 |
UA-DLLME |
8.0 ng/L |
Lv et al. 2014 [99] |
Brassinolide and castasterone |
Pollen of orange (Citrus sinensis Osbeck) |
C18 |
ACN:H2O (80:20) |
Dansylaminophenylboronic acid |
345, 515 |
LLE |
NR |
Motegi et al. 1994 [72] |
Norgestrel, norethindrone, EE2, gestodene, and norethisterone acetate |
Meat samples |
Hypersil GOLD |
Gradient program of (A) H2O containing 5% ACN (B)ACN |
Fmoc-Cl |
250, 395 |
MSPE |
1.4 × 103–8.7 × 103 |
Qianyu Li et al. 2018 [73] |
F and E |
Human urine samples |
C18 |
ACN:0.3 mM orthophosphoric acid (470: 530) |
9-AN |
360, 460 |
LLE |
LLOQ: F: 27.6 nmol/L E: 27.7 nmol/L |
Kosicka et al. 2018 [49] |
FFA |
Edible oils and foodstuff |
C8 |
Gradient system: A: H2O B: ACN/DMF (1:1) C: ACN (100%) |
BCETS |
279, 380 |
Supercritical CO2 and organic solvent extraction |
0.22–1.06 ng/mL |
Li et al. 2011 [74] |
OP, NP, TBP, BPA, E1, E2, E3 |
Milk samples |
C18 |
Gradient program of A:5% ACN in H2O B: ACN |
BQEIC |
302, 401 |
LLE |
10.5–13.8 ng/L |
Liu et al. 2018 [75] |
E3, 2-OHE2, 17β-E2, 17α-E2, EE2, HEX |
Dairy products |
C18 |
Gradient Flow A: 1 mM formic acid in ACN B: 1 mM formic acid at pH 3.50 |
- |
280, 310/320 |
HF-LPME |
0.23–14.8 μg/kg |
Bárbara Socas-Rodríguez et al. 2014 [36] |
Zearalenone |
Edible oil |
C18 |
Gradient program of A: H2O, B: ACN |
|
274, 456 |
SPE |
10 μg/kg |
Drzymala et al. 2015 [100] |
EE2, E1, E2, E3, and progesterone |
Drinking water and wastewater samples |
C18 |
Gradient program of A: H2O/CH3CN 90/10 v/v B: CH3CN |
|
200, 315 |
SPE |
Drinking water: 1–3.8 ng/L Sewage water: 3.8–7.5 ng/L |
Kozłowska-Tylingo et al. 2015 [20] |
E3, E2, E1 |
Human urine |
C18 |
Gradient program of A: H2O, B: ACN |
|
280, 310 |
VA-DLLME-FOA |
E3: 0.01 ng/mL β-E2: 0.01 ng/mL E1: 0.06 ng/mL |
Wang et al. 2015 [82] |
17-α-E2, 17-β-E2 benzoate and quinestrol |
Environmental water samples |
Zorbax Eclipse SB-C18 |
Gradient program of A: ACN, B: H2O |
|
265, 311 |
IF-IHLME |
17-α-Estradiol: 0.04 ng/mL E2 and Quinestrol: 0.05 ng/mL |
Zhang et al. 2017 [101] |
E2 and EE2 |
Tap water samples |
Pursuit 5 C18 column |
ACN:H2O (50:50), with 200 μL of H3PO4 |
|
230, 306 |
Nanoparticles of graphene oxide/γ-Fe2O3 as a sorbent for SPE |
E2: 2.7 ng/L EE2: 0.8 ng/L |
Fernanda Nunes Ferreira et al. 2020 [102] |
17-E2 and E3 |
Water samples |
C18 |
H2O:MeOH:ACN (50:30:20) |
|
280, 310 |
ultrasonication assisted DLLME |
DLLME-HPLC/FLD: 7.16–69.22 ng/L |
Zhang et al. 2020 [14] |
E2, 1,3,5(10)-Estratriene-3,17β-diol |
Fish and prawn tissue samples |
ODS C18 |
H2O:MeOH (30:70) |
|
280,310 |
MISPE |
0.023 mg/L |
Jiang et al. 2009 [40] |
BPA, EE2, 4-t- OP, 4-OP, and 4-NP |
River water |
C18 |
Gradient program of A: ACN B: H2O |
|
277, 307 |
Disposable pipette extraction (DPX) |
BPA, EE2, 4-OP and 4-NP: 0.30 μg/L 4-t-OP: 0.60 μg/L |
Gabriela Corazza et al. 2017 [103] |
E1 and EE2 |
Digested sludge |
C18-PFP |
A: H2O B: ACN E1: (50:50) EE2 (55:45) |
|
280, 310 |
ultrasonic liquid extraction |
E1: 0.305 μg/g EE2: 0.052 μg/g |
Vitória L. Louros et al. 2019 [104] |
E2 |
Milk sample |
XDB-C18 |
MeOH:H2O (70:30) |
|
280, 310 |
SPE |
0.7 ng/mL |
Yanan Yuan et al. 2019 [105] |
Nine BPs |
milk samples |
C18 |
Gradient program of 0.1% formic acid: ACN |
|
230, 305 |
ultrasonically with acetonitrile and cleaned using the QuEChERS technique. |
1.0–3.1 µg/kg |
Xiong et al. 2017 [38] |
EE |
river water samples |
5C18 MS-II |
ACN: 5.0 mM Tris-HNO3 buffer, pH 7.4 (60:40) |
|
310, 400 |
C18 SPE disk |
7.4 ng/L |
Ali et al. 2020 [64] |
E3, 17β-estradiol glucuronide, 17β-E2, 17α-E2, 17β-E2-3-methyl ether |
wastewater |
UPLC C18 |
Gradient program of water with 0.1% of ammonia: ACN |
|
280, 310 |
Molecularly Imprinted SPE |
1.4 to 2.5 ng/mL |
Rayco Guedes-Alonso et al. 2015 [41] |